Narula, N. and Hamam, H. (2023) “Selective JAK1 Inhibition Using Upadacitinib for the Management of Inflammatory Bowel Diseases: The Powerful Pill”, Canadian IBD Today. Toronto, Canada, 1(S11), pp. 2–11. doi: 10.58931/cibdt.2023.1S1121.